Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.88 | 20.95 |
| PEG Ratio (TTM) | -2.41 | 2.42 |
| P/S Ratio (TTM) | 0.51 | 1.49 |
| P/B Ratio (TTM) | 1.07 | 6.64 |
| P/FCF Ratio (TTM) | 14.08 | 14.66 |
| Price to 5YR AVG Earnings Ratio | N/A | 21.55 |
| Price to 5YR AVG FCF Ratio | N/A | 16.61 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.25% | 5.29% |
| ROE (TTM) | -17.57% | 37.75% |
| Net Profit Margin (TTM) | -8.53% | 5.07% |
| ROIC 5YR AVG | N/A | 15.44% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -132.91% | -167.88% | N/A |
| Revenue | 4.05% | 25.88% | N/A |
| Net Income | -141.74% | -170.46% | N/A |
| Cash Flow | 15.42% | 37.48% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.09 | 1.59 |
| Quick Ratio (TTM) | 1.08 | 0.87 |
| D/E Ratio (TTM) | 1.47 | 1.45 |
| Interest Coverage (TTM) | -0.31 | 18.40 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.00 | 3.68 |
| LTL to 5YR AVG FCF | N/A | 7.16 |
| Shares Outstanding Growth 5YR AVG | N/A | -2.44% |